injections tirzepatide FDA Grants a New Indication for Obesity Management Tirzepatide - Weightloss Medicine

In her free time, Gabrielle can be found coaching CrossFit, reviewing pleasure products, hiking with her border collie, or recording episodes of the podcast she co-hosts called Bad In Bed

New England Journal of Medicine: Retatrutide Phase 2 trial results - The landmark study establishing retatrutide efficacy and safety across multiple dose groups New England Journal of Medicine: STEP 1 semaglutide trial results - The pivotal trial demonstrating semaglutide 2.4 mg weight loss efficacy ClinicalTrials.gov: Retatrutide TRIUMPH program - Current status and details of all ongoing Phase 3 retatrutide trials FDA prescribing information for Wegovy (semaglutide 2.4 mg) - Complete approved labeling including dosing, safety, and clinical data New England Journal of Medicine: SELECT cardiovascular outcomes trial - The trial demonstrating semaglutide 20% reduction in major cardiovascular events These primary sources should be the foundation for any serious evaluation of either compound

Our long-term goal is to work up to at least 250 minutes weekly of moderate intensity physical activity, which has been shown to be helpful for weight loss maintenance. Read about 8 effective exercises for weight loss

For people using semaglutide primarily for weight loss, the SELECT data is particularly meaningful

doi: 10.1001/archpsyc.64.3.327 53 DuricV.BanasrM.LicznerskiP.SchmidtH